Abstract

In-stent restenosis (ISR) after angioplasty/stenting for intracranial stenosis has been reported in up to 25% to 30% of patients. Detection and monitoring of ISR relies primarily on serial catheter angiography, because noninvasive imaging methods are typically hampered by stent-related artifact. We examined the value of serial vessel flow measurements using quantitative magnetic resonance angiography (QMRA) in detection of ISR. Records of patients undergoing stenting for intracranial symptomatic stenosis >50% between 2005 and 2009 were retrospectively reviewed. Angiographic images were graded by a blinded neurointerventionalist for stenosis pretreatment, immediately after treatment, and during follow-up. Flow in the affected vessel measured by QMRA was recorded; > 25% reduction in flow was considered indicative of an adverse change. Clinical data regarding neurological outcome were also collected. Twenty-eight patients underwent stenting during the time interval studied. Of these, 12 patients (mean age, 55.5 years; 8 female) had contemporaneous angiography and QMRA and were analyzed. Median follow-up was 9 months. Six patients (50%) demonstrated angiographic restenosis 2 to 12 months after treatment; all had an analogous decrease in flow in the vessel of interest. Of 3 patients with more severe flow decrement (> 50%), 2 experienced stroke. None of the patients without angiographic ISR demonstrated a flow decrease on QMRA. In this preliminary series, flow decrease on QMRA is highly predictive of angiographic ISR. Additionally, the degree of flow decrement correlates with symptomatic ISR. QMRA may provide a useful noninvasive tool for serial monitoring after intracranial stenting.

Highlights

  • Background and PurposeIn-stent restenosis (ISR) after angioplasty/stenting for intracranial stenosis has been reported in up to 25% to 30% of patients

  • None of the patients without angiographic in-stent restenosis (ISR) demonstrated a flow decrease on quantitative magnetic resonance angiography (QMRA). In this preliminary series, flow decrease on QMRA is highly predictive of angiographic ISR

  • Symptomatic intracranial stenosis has a high risk of recurrent stroke despite medical therapy.[3]

Read more

Summary

Methods

Records of patients undergoing stenting for intracranial symptomatic stenosis Ͼ50% between 2005 and 2009 were retrospectively reviewed. Flow in the affected vessel measured by QMRA was recorded; Ͼ25% reduction in flow was considered indicative of an adverse change. Clinical data regarding neurological outcome were collected. A retrospective review of all patients undergoing intracranial angioplasty/stenting for intracranial stenosis over a 4-year period from January 2005 through December 2009 was performed with Institutional Review Board approval. Patients who had undergone contemporaneous imaging follow-up with angiography and QMRA were selected and analyzed. Clinical data regarding neurological symptoms and outcome were collected. Flow measurements of the major intracranial vessels were performed using the technique of blood flow quantification by QMRA previously described[8] and implemented with commercially available software called Noninvasive Optimal Vessel Analysis (NOVA) (VasSol Inc., Chicago, Ill).

Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.